Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 26

1.

Walking the AID tightrope.

Lee-Theilen M, Chaudhuri J.

Nat Immunol. 2010 Feb;11(2):107-9. doi: 10.1038/ni0210-107. Review. No abstract available.

PMID:
20084065
2.

AID hits the jackpot when missing the target.

Kenter AL, Kumar S, Wuerffel R, Grigera F.

Curr Opin Immunol. 2016 Apr;39:96-102. doi: 10.1016/j.coi.2016.01.008. Epub 2016 Feb 1. Review.

3.

Activation-induced deaminase: light and dark sides.

de Yébenes VG, Ramiro AR.

Trends Mol Med. 2006 Sep;12(9):432-9. Epub 2006 Jul 24. Review.

PMID:
16861038
4.

Complex regulation and function of activation-induced cytidine deaminase.

Stavnezer J.

Trends Immunol. 2011 May;32(5):194-201. doi: 10.1016/j.it.2011.03.003. Epub 2011 Apr 13. Review.

5.

Effects of aging on B cell function.

Frasca D, Blomberg BB.

Curr Opin Immunol. 2009 Aug;21(4):425-30. doi: 10.1016/j.coi.2009.06.001. Epub 2009 Jul 14. Review.

6.

Regulation of aicda expression and AID activity: relevance to somatic hypermutation and class switch DNA recombination.

Xu Z, Pone EJ, Al-Qahtani A, Park SR, Zan H, Casali P.

Crit Rev Immunol. 2007;27(4):367-97. Review.

7.

Regulation of AID, the B-cell genome mutator.

Keim C, Kazadi D, Rothschild G, Basu U.

Genes Dev. 2013 Jan 1;27(1):1-17. doi: 10.1101/gad.200014.112. Review.

8.
9.

Mechanism and control of class-switch recombination.

Manis JP, Tian M, Alt FW.

Trends Immunol. 2002 Jan;23(1):31-9. Review.

PMID:
11801452
10.

DNA targets of AID evolutionary link between antibody somatic hypermutation and class switch recombination.

Hackney JA, Misaghi S, Senger K, Garris C, Sun Y, Lorenzo MN, Zarrin AA.

Adv Immunol. 2009;101:163-89. doi: 10.1016/S0065-2776(08)01005-5. Review.

PMID:
19231595
11.
12.

Regulation of immunoglobulin class-switch recombination: choreography of noncoding transcription, targeted DNA deamination, and long-range DNA repair.

Matthews AJ, Zheng S, DiMenna LJ, Chaudhuri J.

Adv Immunol. 2014;122:1-57. doi: 10.1016/B978-0-12-800267-4.00001-8. Review.

13.

AID targeting in antibody diversity.

Pavri R, Nussenzweig MC.

Adv Immunol. 2011;110:1-26. doi: 10.1016/B978-0-12-387663-8.00005-3. Review.

PMID:
21762814
14.

AID: a riddle wrapped in a mystery inside an enigma.

Upton DC, Gregory BL, Arya R, Unniraman S.

Immunol Res. 2011 Apr;49(1-3):14-24. doi: 10.1007/s12026-010-8190-x. Review.

PMID:
21128007
15.

Oncogenic events triggered by AID, the adverse effect of antibody diversification.

Pérez-Durán P, de Yebenes VG, Ramiro AR.

Carcinogenesis. 2007 Dec;28(12):2427-33. Epub 2007 Sep 4. Review.

PMID:
17804422
16.

Potential roles of activation-induced cytidine deaminase in promotion or prevention of autoimmunity in humans.

Durandy A, Cantaert T, Kracker S, Meffre E.

Autoimmunity. 2013 Mar;46(2):148-56. doi: 10.3109/08916934.2012.750299. Epub 2013 Jan 10. Review.

17.

Activation-induced cytidine deaminase in antibody diversification and chromosome translocation.

Gazumyan A, Bothmer A, Klein IA, Nussenzweig MC, McBride KM.

Adv Cancer Res. 2012;113:167-90. doi: 10.1016/B978-0-12-394280-7.00005-1. Review.

18.
19.

Post-translational regulation of activation-induced cytidine deaminase.

Basu U, Franklin A, Alt FW.

Philos Trans R Soc Lond B Biol Sci. 2009 Mar 12;364(1517):667-73. doi: 10.1098/rstb.2008.0194. Review.

20.

Activation-induced cytidine deaminase structure and functions: a species comparative view.

Barreto VM, Magor BG.

Dev Comp Immunol. 2011 Sep;35(9):991-1007. doi: 10.1016/j.dci.2011.02.005. Epub 2011 Feb 22. Review.

PMID:
21349283

Supplemental Content

Support Center